# Harbor MedTech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/harbor-medtech

- Industry: Biotechnology
- Headquarters: Irvine, US
- Website: www.harbormedtech.com
- Total disclosed funding: $0.2M
- Latest round: Series B (Nov 9, 2016)
- Investors on record: 1

## About

Harbor MedTech Inc. is a medical technology firm that specializes in innovative orthopedic soft tissue repair solutions, primarily through its patented BriDGE® technology, enhancing healing processes in various surgical applications.Founded in 2010 by Jim Jungwirth and Keith Myers, Harbor MedTech Inc. is based in Irvine, US. The company focuses on advanced orthopedic technologies and has successfully raised USD 0.2 million in Series B funding from Alumni Ventures Group in November 2016. The firm has completed a total of 8 deals to date, further establishing its presence in the medical technology sector.Harbor MedTech, Inc. specializes in advanced orthopedic soft tissue repair solutions through its patented BriDGE® technology, which transforms intact Type-1 collagen into a stabilized collagen matrix, promoting natural healing. The company offers two FDA-cleared and CE-marked products addressing chronic skin wounds, internal soft tissue injuries, and general surgical repairs such as hernia and breast reconstruction. Their products are marketed to healthcare providers in the US and Europe, aiming to enhance wound healing and tissue regeneration while minimizing scar tissue formation and infection risk.Harbor MedTech generates revenue through direct sales of its patented BriDGE® processed collagen matrix to healthcare facilities involved in orthopedic and surgical procedures. Revenue is recognized upon product delivery and acceptance, primarily through one-time sales agreements, though partnerships with medical institutions may support bulk purchasing. Pricing for products is established based on contractual agreements with clients, reflecting their advanced regenerative solutions.Looking ahead, Harbor MedTech plans to utilize recent funding to support the development of new products aimed at enhancing their product portfolio and addressing additional medical needs. The company is also targeting expansion into new markets, including broader outreach in Europe and potential entry into Asian markets by 2025. The recent Series B funding of USD 0.2 million will facilitate these initiatives, allowing Harbor MedTech to further innovate and meet the growing demand for effective soft tissue repair solutions.

## Funding rounds

- Series B, Nov 9, 2016, $0.2M — Alumni Ventures Group

## Investors

- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series B